Evidence map›Paper›PMID 35265454›Full record

ArticleAnalytical cellular pathology (Amsterdam)2022

Lymphocyte Activation Gene 3 Single-Nucleotide Polymorphisms in Bone Marrow Failure Diseases.

Yingying Sun, Qiuying Cao, Xiaoyu Zhao, Chunyan Liu, Zonghong Shao

Open access · goldAbstract read
In one paragraph

Article in Analytical cellular pathology (Amsterdam), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Elevated Allele Frequency and Male-Predominance of a CommonCurrent issues in molecular biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yingying SunDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-0788-7076
Qiuying CaoDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-9602-0190
Xiaoyu ZhaoDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-2758-8006
Chunyan LiuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID https://orcid.org/0000-0001-8965-9650
Zonghong ShaoDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-4581-0774
Tianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lymphocyte activation gene 3 (LAG3) is an inhibitory checkpoint protein expressed on activated T effector, T regulatory, and natural killer cells. The main function of LAG3 is the regulation of immune homeostasis. Several studies have suggested its role in malignant and autoimmune diseases. The objective of this study was to explore the association between Methods: Sixty-two patients newly diagnosed with bone marrow failure diseases in the Hematology Department of Tianjin Medical University General Hospital between January 2019 and December 2020 and 16 healthy controls were enrolled in this study. SNPs in Results: Eleven SNPs were identified. Among them, the frequency of LAG3 rs1941928301 (C>T) was statistically different among the groups ( Conclusions: LAG3 rs1941928301 (C>T) might be associated with a higher risk of MDS. The detected

Indexed as

Antigens, CDBone Marrow Failure DisordersPancytopeniaHumansLymphocyte Activation Gene 3 ProteinPolymorphism, Single NucleotideAntigens, CDLag3 protein, humanLymphocyte Activation Gene 3 Protein

Identifiers

PMID35265454
PMCPMC8898880
OpenAlexW4214717849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.